HOSAKA Yoshitaka | Pharmaceutical Research Center, Mochida Pharmaceutical Co., Ltd.

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Synthesis and Evaluation of 1-Arylsulfonyl-3-piperazinone Derivatives as Factor Xa Inhibitors III. Effect of Ring Opening of Piperazinone Moiety on Inhibition
Synthesis and Evaluation of 1-Arylsulfony1-3-piperazinone Derivatives as Factor Xa Inhibitors^ IV. A Series of New Derivatives Containing a Spiro [5H-oxazolo [3, 2-a] pyrazine-2 (3H), 4'-piperidin] -5-one Skeleton
Synthesis and Evaluation of 1-Arylsulfonyl-3-piperazinone Derivatives as a Factor Xa Inhibitor II. Substituent Effect on Biological Activities
Synthesis and Evaluation of 1-Arylsulfonyl-3-piperazinone Derivatives as Factor Xa Inhibitor
Synthesis and Evaluation of 1-Arylsulfonyl-3-piperazinone Derivatives as Factor Xa Inhibitors^ V. A Series of New Derivatives Containing a Spiro [imidazo [1,2-a] pyrazine-2(3H),4'-piperidin]-5(1H)-one Scaffold
Synthesis and Evaluation of 1-Arylsulfonyl-3-piperazinone Derivatives as Factor Xa Inhibitors VI. A Series of New Derivatives Containing N,S- and N,SO_2-Spiro Acetal Scaffolds

スポンサーリンク